Related Experiment Video
Updated: Oct 19, 2026

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
Mitotic checkpoint inactivation fosters transformation in cells lacking the breast cancer susceptibility gene, Brca2
H Lee1, A H Trainer, L S Friedman
1Medical Research Council, Laboratory of Molecular Biology, Cambridge, United Kingdom.
Abstract:
The murine Brca2 gene encodes a nuclear protein implicated in DNA repair. Brca2 behaves as a tumor suppressor, but paradoxically, its truncation causes proliferative arrest and spontaneous chromosomal damage. Here, we report that inactivation of cell cycle checkpoints responsive to mitotic spindle disruption, by mutant forms of p53 or Bub1, relieves growth arrest and initiates neoplastic transformation in primary cells homozygous for truncated Brca2. Tumors from Brca2-deficient animals exhibit dysfunction of the spindle assembly checkpoint, accompanied by mutations in p53, Bub1, and Mad3L. The chromosomal aberrations precipitated by Brca2 truncation can be suppressed by mutant forms of Bub1 and p53. Thus, inactivating mutations in mitotic checkpoint genes likely cooperate with BRCA2 deficiency in the pathogenesis of inherited breast cancer, with important implications for treatment.
Insights
Truncated Brca2 causes DNA damage and cell cycle arrest. Inactivating cell cycle checkpoints with mutant p53 or Bub1 promotes tumor development in Brca2-deficient cells, suggesting a role in inherited breast cancer.
Area of Science:
- Genetics
- Molecular Biology
- Cancer Research
Background:
- The murine Brca2 gene is crucial for DNA repair and acts as a tumor suppressor.
- Truncation of Brca2 paradoxically leads to cell proliferation arrest and chromosomal damage.
Purpose of the Study:
- To investigate how inactivation of cell cycle checkpoints affects neoplastic transformation in Brca2-deficient cells.
- To explore the role of mitotic checkpoint genes in the pathogenesis of inherited breast cancer.
Main Methods:
- Utilizing primary cells homozygous for truncated Brca2.
- Employing mutant forms of p53 and Bub1 to inactivate cell cycle checkpoints.
- Analyzing tumors from Brca2-deficient animals for spindle assembly checkpoint function and mutations.
Main Results:
- Inactivation of cell cycle checkpoints by mutant p53 or Bub1 relieved growth arrest and initiated neoplastic transformation in Brca2-deficient cells.
- Brca2-deficient tumors showed spindle assembly checkpoint dysfunction and mutations in p53, Bub1, and Mad3L.
- Mutant forms of Bub1 and p53 suppressed chromosomal aberrations caused by Brca2 truncation.
Conclusions:
- Inactivating mutations in mitotic checkpoint genes likely cooperate with BRCA2 deficiency in inherited breast cancer development.
- Understanding this cooperation has significant implications for breast cancer treatment strategies.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Inhibition of Cdk Activity
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...

